Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 95.09 USD 0.15% Market Closed
Market Cap: 8.3B USD
Have any thoughts about
Healthequity Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one HQY stock under the Base Case scenario is 95.75 USD. Compared to the current market price of 95.09 USD, Healthequity Inc is Undervalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HQY Relative Value
Base Case
95.75 USD
Undervaluation 1%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
41
vs Industry
21
Median 3Y
6.4
Median 5Y
6.7
Industry
2.3
Forward
6.9
More Details
85.4
P/E
P/E
Price to Earnings
85.4
vs History
46
vs Industry
5
Median 3Y
-88
Median 5Y
78.4
Industry
23.1
Forward
30.1
More Details
24.2
P/OCF
P/OCF
Price to OCF
24.2
vs History
92
vs Industry
17
Median 3Y
29
Median 5Y
33
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
9
Median 3Y
-72.2
Median 5Y
-30.1
Industry
20.1
More Details
3.9
P/B
P/B
Price to Book Value
3.9
vs History
22
vs Industry
28
Median 3Y
3
Median 5Y
3.2
Industry
2.2
More Details
7.8
EV/S
EV/S
Enterprise Value to Sales
7.8
vs History
42
vs Industry
17
Median 3Y
7.1
Median 5Y
7.5
Industry
2.4
Forward
7.5
More Details
12
EV/GP
EV/GP
Enterprise Value to Gross Profit
12
vs History
69
vs Industry
19
Median 3Y
11.9
Median 5Y
12.6
Industry
5
More Details
25
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25
vs History
82
vs Industry
13
Median 3Y
26.7
Median 5Y
28.4
Industry
12.7
Forward
18.7
More Details
45.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.1
vs History
90
vs Industry
7
Median 3Y
84.5
Median 5Y
73.1
Industry
17.1
Forward
47.7
More Details
26.4
EV/OCF
EV/OCF
Enterprise Value to OCF
26.4
vs History
92
vs Industry
16
Median 3Y
30.9
Median 5Y
36.1
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
12
Median 3Y
37.1
Median 5Y
64.5
Industry
18
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
9
vs Industry
32
Median 3Y
2.3
Median 5Y
2.3
Industry
1.9
More Details

Multiples Across Competitors

HQY Competitors Multiples
Healthequity Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Healthequity Inc
NASDAQ:HQY
8.3B USD 7.2 85.4 25 45.1
US
UnitedHealth Group Inc
NYSE:UNH
467.6B USD 1.2 32.7 13.9 15.7
US
Anthem Inc
LSE:0HG8
95.9B USD 0.6 14.9 10.6 12.3
US
Elevance Health Inc
NYSE:ELV
86B USD 0.5 13.4 9.7 11.2
US
Centene Corp
NYSE:CNC
30.7B USD 0.2 10 7.2 10.1
US
Humana Inc
NYSE:HUM
30.8B USD 0.3 22.7 8.5 10.9
US
Molina Healthcare Inc
NYSE:MOH
16.8B USD 0.4 14.7 5.5 6.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
17.1B BRL 1 -40 7 15.8
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 7.6 11.1 33
US
Clover Health Investments Corp
NASDAQ:CLOV
1.6B USD 1.1 -17.8 -18.5 -18.1
US
Progyny Inc
NASDAQ:PGNY
1.3B USD 1.1 22.4 15.3 16
P/E Multiple
Earnings Growth P/E to Growth
US
Healthequity Inc
NASDAQ:HQY
Average P/E: 24.8
85.4
615%
0.1
US
UnitedHealth Group Inc
NYSE:UNH
32.7
40%
0.8
US
A
Anthem Inc
LSE:0HG8
14.9
60%
0.2
US
Elevance Health Inc
NYSE:ELV
13.4
60%
0.2
US
Centene Corp
NYSE:CNC
10
51%
0.2
US
Humana Inc
NYSE:HUM
22.7
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
14.7
56%
0.3
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -40 N/A N/A
US
M
Magellan Health Inc
F:MAH1
7.6
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.8 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
22.4
25%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Healthequity Inc
NASDAQ:HQY
Average EV/EBITDA: 11.4
25
136%
0.2
US
UnitedHealth Group Inc
NYSE:UNH
13.9
32%
0.4
US
A
Anthem Inc
LSE:0HG8
10.6
20%
0.5
US
Elevance Health Inc
NYSE:ELV
9.7
20%
0.5
US
Centene Corp
NYSE:CNC
7.2
6%
1.2
US
Humana Inc
NYSE:HUM
8.5
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
5.5
39%
0.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
7
72%
0.1
US
M
Magellan Health Inc
F:MAH1
11.1
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.5 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
15.3
262%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Healthequity Inc
NASDAQ:HQY
Average EV/EBIT: 17.6
45.1
174%
0.3
US
UnitedHealth Group Inc
NYSE:UNH
15.7
36%
0.4
US
A
Anthem Inc
LSE:0HG8
12.3
31%
0.4
US
Elevance Health Inc
NYSE:ELV
11.2
31%
0.4
US
Centene Corp
NYSE:CNC
10.1
20%
0.5
US
Humana Inc
NYSE:HUM
10.9
-38%
N/A
US
Molina Healthcare Inc
NYSE:MOH
6.1
41%
0.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
15.8
191%
0.1
US
M
Magellan Health Inc
F:MAH1
33
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.1 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
16
217%
0.1

See Also

Summary
HQY intrinsic value, competitors valuation, and company profile.
DCF Valuation
HQY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HQY stock valuation using valuation multiples.
Wall Street Estimates
HQY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HQY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.